Results 21 to 30 of about 6,002 (227)

The SABRE project and the SABRE Proof-of-Principle [PDF]

The European Physical Journal C, 2019
SABRE aims to directly measure the annual modulation of the dark matter interaction rate with NaI(Tl) crystals. A modulation compatible with the standard hypothesis, in which our Galaxy is immersed in a dark matter halo, has been measured by the DAMA experiment in the same target material.
Antonello, M., Barberio, E., Baroncelli, T., Benziger, J., Bignell, L. J., Bolognino, I., Calaprice, F., Copello, S., D’Angelo, D., D’Imperio, G., Dafinei, I., Di Carlo, G., Diemoz, M., Di Ludovico, A., Dix, W., Duffy, A. R., Froborg, F., Giovanetti, G. K., Hoppe, E., Ianni, A., Ioannucci, L., Krishnan, S., Lane, G. J., Mahmood, I., Mariani, A., Mastrodicasa, M., Montini, P., Mould, J., Nuti, F., Orlandi, D., Paris, M., Pettinacci, V., Pietrofaccia, L., Prokopovic, D., Rahatlou, S., Rossi, N., Sarbutt, A., Shields, E., Souza, M. J., Stuchbery, A. E., Suerfu, B., Tomei, C., Toso, V., Urquijo, P., Vignoli, C., Wada, M., Wallner, A., Williams, A. G., Xu, J.   +48 more
openaire   +6 more sources

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care

Current Oncology, 2021
Background: Recent clinical trial results reported that stereotactic radiotherapy (SABR) may improve survival for patients with oligometastatic (OM) cancer. Given that these results come from a phase II trial, there remains considerable uncertainty about
Adam J. N. Raymakers, David Cameron, Scott Tyldesley, Dean A. Regier   +3 more
doaj   +1 more source

Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis

Radiation Oncology, 2021
Background The purpose of this study was to compare the treatment efficacy and safety of re-irradiation (re-RT) using stereotactic ablative radiotherapy (SABR) and initial SABR for primary, recurrent lung cancer or metastatic lung tumor.
Tae Hoon Lee, Dong-Yun Kim, Hong-Gyun Wu, Joo Ho Lee, Hak Jae Kim   +4 more
doaj   +1 more source

Sabres [PDF]

ADLFI. Archéologie de la France - Informations, 2008
Identifiant de l'operation archeologique : 025369 Date de l'operation : 2008 (FP) Engagee en 2005 dans le cadre du PCR « Airiaux de la Grande Lande », la reconnaissance archeologique du sol de la maison dite « Malichecq » n’avait pu etre que partiellement menee a bien en raison de problemes de securite lies a l’instabilite de sa structure.
Laborie, Yan, Laborie, Yan
openaire   +1 more source

Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study

Radiation Oncology, 2021
Background Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging assessment of response after SABR is difficult.
Dae-Myoung Yang, David A. Palma, Keith Kwan, Alexander V. Louie, Richard Malthaner, Dalilah Fortin, George B. Rodrigues, Brian P. Yaremko, Joanna Laba, Stewart Gaede, Andrew Warner, Richard Inculet, Ting-Yim Lee   +12 more
doaj   +1 more source

Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease

Frontiers in Oncology, 2021
BackgroundIn certain malignancies, patients with oligometastatic disease benefit from radical ablative or surgical treatment. The SABR-COMET trial demonstrated a survival benefit for oligometastatic patients randomized to local stereotactic ablative ...
Dirk Mehrens, Marcus Unterrainer, Stefanie Corradini, Maximilian Niyazi, Farkhad Manapov, C. Benedikt Westphalen, Matthias F. Froelich, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Johannes Rübenthaler, Wolfgang G. Kunz   +11 more
doaj   +1 more source

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

Advances in Radiation Oncology, 2021
Purpose: Oligoprogression, defined as limited sites of progression on systemic therapy, in patients with metastatic renal cell carcinoma (mRCC) is not uncommon, possibly because of inter- and intratumoral heterogeneity.
Jonathan E. Schoenhals, BS, Osama Mohamad, MD, PhD, Alana Christie, MS, Yuanyuan Zhang, MD, PhD, Daniel Li, MD, Nirmish Singla, MD, MSCS, Isaac Bowman, MD, Waddah Arafat, MD, Hans Hammers, MD, Kevin Courtney, MD, PhD, Suzanne Cole, MD, Aditya Bagrodia, MD, Vitaly Margulis, MD, Neil Desai, MD, Aurelie Garant, MD, Hak Choy, MD, Robert Timmerman, MD, James Brugarolas, MD, PhD, Raquibul Hannan, MD, PhD   +18 more
doaj   +1 more source

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2021
Ashwathy S Mathew,1 Laura A Dawson2,3 1Department of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India; 2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; 3Department of Radiation Oncology ...
Mathew AS, Dawson LA
doaj  

Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study

Journal for ImmunoTherapy of Cancer, 2023
Stereotactic ablative body radiation (SABR) delivers high rates of local control in early-stage non-small cell lung cancer (NSCLC); however, systemic immune effects are poorly understood.
Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Valsamo Anagnostou, Cheng Ting Lin, Peter B Illei, Kellie N Smith, Mara Lanis, Khinh Ranh Voong, Bradley Presson, Dipika Singh, Zhen Zeng, Russell K Hales, Phuoc T Tran, Christos Georgiades, Jeffrey Thiboutout   +15 more
doaj   +1 more source

SabR enhances nikkomycin production via regulating the transcriptional level of sanG, a pathway-specific regulatory gene in Streptomyces ansochromogenes

BMC Microbiology, 2011
Background sabR is a pleiotropic regulatory gene which has been shown to positively regulate the nikkomycin biosynthesis and negatively affect the sporulation of Streptomyces ansochromogenes.
Liu Gang, Tian Yuqing, He Xihong, Wang Linqi, Pan Yuanyuan, Tan Huarong   +5 more
doaj   +1 more source